4-Methylcoumarin derivatives with anti-inflammatory effects in activated microglial cells

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 1, 2014, Pages 60-66

  Togna, Anna Rita ^a   Firuzi, Omidreza ^b   Latina, Valentina ^a   Parmar, Virinder Singh ^c   Prasad, Ashok Kumar ^c   Salemme, Adele ^a   Togna, Giuseppina Ines ^a   Saso, Luciano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF DELHI   (India)

Author keywords

4 Methylcoumarin; Cyclooxygenase 2 (COX 2); Inducible nitric oxide synthase (iNOS); Inflammation; Microglia

Indexed keywords

7,8 DIACETOXY 3 ETHOXYCARBONYLMETHYL 4 METHYLCOUMARIN; 7,8 DIHYDROXY 3 ETHOXYCARBONYLMETHYL 4 METHYLCOUMARIN; COUMARIN DERIVATIVE; CYCLOOXYGENASE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROSTAGLANDIN E2; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; IN VITRO STUDY; MICROGLIA; NERVE CELL CULTURE; NONHUMAN; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COUMARINS; CYCLOOXYGENASE 2; DINOPROSTONE; INFLAMMATION; INFLAMMATION MEDIATORS; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; RATS; THROMBOXANE B2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892578616     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00568     Document Type: Article

References (29)

1. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanché H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alpérovitch A, Lathrop M, Amouyel P; European Alzheimer's Disease Initiative Investigators. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet., 41, 1094-1099 (2009).
2. Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ, 327, 128-131 (2003)
3. Khandelwal PJ, Herman AM, Moussa CE. Inflammation in the early stages of neurodegenerative pathology. J. Neuroimmunol., 238, 1-11 (2011).
4. Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P. Soothing the inflamed brain: Effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology. CNS Neurol. Disord. Drug Targets, 10, 57-67 (2011).
5. Kostova I. Synthetic and natural coumarins as cytotoxic agents. Curr. Med. Chem., 5, 29-46 (2005).
6. Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr. Med. Chem., 12, 887-916 (2005).
7. Melagraki G, Afantitis A, Igglessi-Markopoulou O, Detsi A, Koufaki M, Kontogiorgis C, Hadjipavlou-Litina DJ. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur. J. Med. Chem., 44, 3020-3026 (2009).
8. Nakamura T, Kodama N, Oda M, Tsuchiya S, Arai Y, Kumamoto T, Ishikawa T, Ueno K, Yano S. The structure-activity relationship between oxycoumarin derivatives showing inhibitory effects on iNOS in mouse macrophage RAW264.7 cells. J. Nat. Med., 63, 15-20 (2009).
9. Sandhya B, Giles D, Mathew V, Basavarajaswamy G, Abraham R. Synthesis, pharmacological evaluation and docking studies of coumarin derivatives. Eur. J. Med. Chem., 46, 4696-4701 (2011).
10. Rim HK, Cho W, Sung SH, Lee KT. Nodakenin suppresses lipopolysaccharide- induced inflammatory responses in macrophage cells by inhibiting TRAF6 and NF-kappaB pathways and protects mice from lethal endotoxin shock. J. Pharmacol. Exp. Ther., 342, 654-664 (2012).
11. Kumar S, Singh BK, Kalra N, Kumar V, Kumar A, Prasad AK, Raj HG, Parmar VS, Ghosh B. Novel thiocoumarins as inhibitors of TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs) and microsomal lipid peroxidation. Bioorg. Med. Chem., 13, 1605-1613 (2005).
12. Pedersen JZ, Oliveira C, Incerpi S, Kumar V, Fiore AM, De Vito P, Prasad AK, Malhotra SV, Parmar VS, Saso L. Antioxidant activity of 4-methylcoumarins. J. Pharm. Pharmacol., 59, 1721-1728 (2007).
13. Mladenka P, Macakova K, Zatloukalova L, Rehakova Z, Singh BK, Prasad AK, Parmar VS, Jahodar L, Hrdina R, Saso L. In vitro interactions of coumarins with iron. Biochimie, 92, 1108-1114 (2010)
14. Morabito G, Trombetta D, Singh BK, Prasad AK, Parmar VS, Naccari C, Mancari F, Saija A, Cristani M, Firuzi O, Saso L. Antioxidant properties of 4-methylcoumarins in in vitro cell-free systems. Biochimie, 92, 1101-1107 (2010)
15. Ronad P, Dharbamalla S, Hunshal R, Maddi V. Synthesis of novel substituted 7-(benzylideneamino)-4-methyl-2H-chromen-2-one derivatives as anti-inflammatory and analgesic agents. Arch. Pharm., 341, 696-700 (2008)
16. Kancheva VD, Saso L, Angelova SE, Foti MC, Slavova-Kasakova A, Daquino C, Enchev V, Firuzi O, Nechev J. Antiradical and antioxidant activities of new bio-antioxidants. Biochimie, 94, 403-415 (2012).
17. Kancheva VD, Saso L, Boranova PV, Khan A, Saroj MK, Pandey MK, Malhotra S, Nechev JZ, Sharma SK, Prasad AK, Georgieva MB, Joseph C, DePass AL, Rastogi RC, Parmar VS. Structure-activity relationship of dihydroxy-4-methylcoumarins as powerful antioxidants: correlation between experimental & theoretical data and synergistic effect. Biochimie, 92, 1089-1100 (2010).
18. Parmar V, Singh S, Boll P. 13C Nuclear magnetic resonance spectroscopy of 4-methylcoumarins (4-methyl-2H-1-benzopyran-2-ones). Magn. Reson. Chem., 26, 430-433 (1988).
19. Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci., 6, 2163-2178 (1986).
20. Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, Cipollone F, Ganci A, Créminon C, Maclouf J, Patrono C. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J. Pharmacol. Exp. Ther., 3, 1705-1712 (1994).
21. Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ, Koboldt CM, Muhammad JL, Zweifel BS, Masferrer JL, Isakson PC, Seibert K. Valdecoxib: Assessment of cyclooxygenase-2 potency and selectivity. J. Pharmacol. Exp. Ther., 312, 1206-1212 (2005).
22. Moradi A, Navidpour L, Amini M, Sadeghian H, Shadnia H, Firouzi O, Miri R, Ebrahimi SE, Abdollahi M, Zahmatkesh MH, Shafiee A. Design and synthesis of 2-phenoxynicotinic acid hydrazides as anti-inflammatory and analgesic agents. Arch. Pharm, 343, 509-518 (2010).
23. Doherty GH. Nitric oxide in neurodegeneration: Potential benefits of non-steroidal anti-inflammatories. Neurosci. Bull., 6, 366-382 (2011).
24. Smith JA, Das A, Ray SK, Banik NL. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull., 87, 10-20 (2012).
25. Shin EM, Zhou HY, Guo LY, Kim JA, Lee SH, Merfort I, Kang SS, Kim HS, Kim S, Kim YS. Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages. Int. Immunopharmacol., 8, 1524-1532 (2008).
26. Liao PC, Chien SC, Ho CL, Wang EI, Lee SC, Kuo YH, Jeyashoke N, Chen J, Dong WC, Chao LK, Hua KF. Osthole regulates inflammatory mediator expression through modulating NF-kappaB, mitogen-activated protein kinases, protein kinase C, and reactive oxygen species. J. Agric. Food Chem., 58, 10445-10451 (2010).
27. Goel A, Prasad AK, Parmar VS, Ghosh B, Saini N. Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: Role of NF-kappaB, Akt, ROS and MAP kinase pathway. Chem. Biol. Interact., 179, 363-374 (2009).
28. Raghav SK, Gupta B, Shrivastava A, Das HR. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1′-1′-dimethyl-allyl)-6- hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L. Eur. J. Pharmacol., 560, 69-80 (2007).
29. Yao SY, Natarajan C, Sriram S. nNOS mediated mitochondrial injury in LPS stimulated oligodendrocytes. Mitochondrion, 12, 336-344 (2012).